Edition:
United Kingdom

BeyondSpring Inc (BYSI.OQ)

BYSI.OQ on NASDAQ Stock Exchange Capital Market

17.08USD
8:41pm BST
Change (% chg)

$0.14 (+0.83%)
Prev Close
$16.94
Open
$17.13
Day's High
$17.13
Day's Low
$16.98
Volume
4,098
Avg. Vol
23,478
52-wk High
$26.85
52-wk Low
$13.18

About

BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $892.10
Shares Outstanding(Mil.): 22.84
Dividend: --
Yield (%): --

Financials

  BYSI.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -3.97 -- --
ROI: -268.89 8.95 14.48
ROE: -260.45 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates